| Primary |
| Hepatitis C |
66.6% |
| Chronic Hepatitis C |
12.6% |
| Prophylaxis |
4.5% |
| Product Used For Unknown Indication |
3.5% |
| Hypertension |
2.9% |
| Insomnia |
1.2% |
| Drug Use For Unknown Indication |
1.1% |
| Depression |
1.0% |
| Diabetes Mellitus |
0.9% |
| Hyperlipidaemia |
0.8% |
| Constipation |
0.7% |
| Hiv Infection |
0.7% |
| Pyrexia |
0.7% |
| Hyperuricaemia |
0.6% |
| Hepatitis C Virus Test Positive |
0.4% |
| Iron Deficiency Anaemia |
0.4% |
| Rash |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Hepatitis Chronic Active |
0.4% |
| Gastritis |
0.4% |
|
| White Blood Cell Count Decreased |
14.6% |
| Rash |
10.2% |
| Weight Decreased |
9.0% |
| Pyrexia |
7.7% |
| Vomiting |
5.6% |
| Malaise |
5.0% |
| Nausea |
5.0% |
| Anaemia |
4.8% |
| Platelet Count Decreased |
4.3% |
| Renal Impairment |
4.0% |
| Fatigue |
3.5% |
| Hepatitis C |
3.4% |
| Thrombocytopenia |
3.4% |
| Haemoglobin Decreased |
3.0% |
| Neutropenia |
3.0% |
| Syncope |
3.0% |
| Drug Ineffective |
2.9% |
| Neutrophil Count Decreased |
2.6% |
| Therapeutic Response Decreased |
2.6% |
| Transfusion |
2.6% |
|
| Secondary |
| Hepatitis C |
37.9% |
| Chronic Hepatitis C |
32.7% |
| Prophylaxis |
10.3% |
| Hypertension |
4.1% |
| Product Used For Unknown Indication |
2.3% |
| Hyperlipidaemia |
1.9% |
| Insomnia |
1.4% |
| Diabetes Mellitus |
1.3% |
| Hyperuricaemia |
1.1% |
| Iron Deficiency Anaemia |
1.0% |
| Constipation |
0.9% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Depression |
0.7% |
| Adverse Event |
0.7% |
| Rash |
0.7% |
| Pyrexia |
0.6% |
| Gastritis |
0.6% |
| Drug Use For Unknown Indication |
0.5% |
| Nausea |
0.5% |
| Gastric Ulcer |
0.4% |
|
| White Blood Cell Count Decreased |
17.5% |
| Anaemia |
10.2% |
| Rash |
9.4% |
| Weight Decreased |
6.3% |
| Vomiting |
6.2% |
| Renal Impairment |
6.2% |
| Neutrophil Count Decreased |
4.9% |
| Haemoglobin Decreased |
4.4% |
| Platelet Count Decreased |
3.9% |
| Renal Disorder |
3.8% |
| Retinopathy |
3.8% |
| Malaise |
3.4% |
| Pyrexia |
3.4% |
| Drug Eruption |
3.3% |
| Nausea |
3.1% |
| Decreased Appetite |
2.7% |
| Hyperuricaemia |
2.2% |
| Erythema Multiforme |
2.1% |
| Erythema |
1.8% |
| Loss Of Consciousness |
1.5% |
|
| Concomitant |
| Hepatitis C |
89.0% |
| Chronic Hepatitis C |
2.6% |
| Hiv Infection |
1.8% |
| Hypertension |
1.1% |
| Product Used For Unknown Indication |
1.0% |
| Adverse Event |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Hyperuricaemia |
0.5% |
| Diabetes Mellitus |
0.4% |
| Prophylaxis |
0.4% |
| Prophylaxis Against Transplant Rejection |
0.3% |
| Anaemia |
0.3% |
| Depression |
0.3% |
| Back Pain |
0.2% |
| Prophylaxis Against Graft Versus Host Disease |
0.2% |
| Arrhythmia |
0.2% |
| Liver Transplant |
0.2% |
| Pain |
0.2% |
| Paternal Drugs Affecting Foetus |
0.2% |
| Factor Viii Deficiency |
0.1% |
|
| Anaemia |
11.0% |
| Haemoglobin Decreased |
9.4% |
| White Blood Cell Count Decreased |
8.8% |
| Rash |
8.0% |
| Neutrophil Count Decreased |
7.9% |
| Decreased Appetite |
6.6% |
| Drug Eruption |
6.3% |
| Renal Impairment |
6.2% |
| Renal Disorder |
4.7% |
| Blood Creatinine Increased |
4.6% |
| Erythema Multiforme |
3.8% |
| Malaise |
3.8% |
| Hyperuricaemia |
3.2% |
| Erythema |
3.1% |
| Platelet Count Decreased |
3.1% |
| Nausea |
2.3% |
| Retinopathy |
2.0% |
| Toxic Skin Eruption |
1.9% |
| Pyrexia |
1.6% |
| Renal Failure Acute |
1.5% |
|
| Interacting |
| Chronic Hepatitis C |
50.0% |
| Hepatitis C |
22.2% |
| Prophylaxis |
9.3% |
| Hiv Infection |
7.4% |
| Type 2 Diabetes Mellitus |
3.7% |
| Anaemia |
1.9% |
| Chronic Hepatitis |
1.9% |
| Hepatitis Alcoholic |
1.9% |
| Urinary Tract Infection |
1.9% |
|
| Decreased Appetite |
27.8% |
| Drug Interaction |
22.2% |
| Proctalgia |
11.1% |
| Acute Psychosis |
5.6% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
5.6% |
| Lactic Acidosis |
5.6% |
| Psychotic Disorder |
5.6% |
| Renal Colic |
5.6% |
| Renal Failure Acute |
5.6% |
| Thrombocytopenia |
5.6% |
|
